COTEAUBeta Get App
ALHC

ALHC

Alignment Healthcare, Inc.
$8.40
+1.45% Oct 19 close
Health CareS&P 600
-57%-32%-8%+17%+41%Oct 2025Oct 2026Apr 2026
ALHCSPY
1W
+3.8%
1M
+0.6%
3M
-60.2%
6M
-61.0%
YTD
-57.5%
1Y
-50.9%

Live chart

Loading live chart…

What they do

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

Healthcare · Healthcare Plans

For information only · Important disclosures

Grades vs sector

Momentum
3rd percentile in sector
F
12-1 return: -51.6%
Percentile within its GICS sector across the S&P 1500.
Growth
89th percentile in sector
A
Revenue growth (YoY): +31.6%
Percentile within its GICS sector across the S&P 1500.
Value
63rd percentile in sector
B-
Forward E/P: 7.9% · EBITDA/EV: 6.5%
Percentile within its GICS sector across the S&P 1500.
Profitability
49th percentile in sector
C+
Profit margin: +0.9% · Return on equity: +20.0%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
No recent headlines.

Key stats

52-week range$7.55 – $24.56
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
▲DCF (base case)above the price by 601%
•Piotroski F-score5/9
▲Net debt / EBITDA-4.4x

Discounted cash flow

Bear
$27
+218%
growth 18% · disc. 10.2% · term. 2.0%
Base
$59
+601%
growth 30% · disc. 9.2% · term. 2.5%
Bull
$111
+1218%
growth 38% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Health Care

P/E (trailing)
sector median 29.9×
–
Forward P/E
sector median 17.6×
–
EV / EBITDA
sector median 15.8×
–
Price / sales
sector median 3.1×
–
Price / book
sector median 3.5×
–
FCF yield
sector median 4.1%
–

Quality & financial health

Gross margin
–
Operating margin
1.2%
FCF margin
3.9%
Net margin
0.9%
Return on equity
15.4%
Return on invested capital
–
Net debt / EBITDA
-4.4×
Current ratio
1.7×
Interest cover
3.4×
Cash conversion (OCF/NI)
5.1×
Piotroski F-score 5/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✓ Asset turnover improved

Analysts

No analyst targets available.

Annual history

FYRevenueNet incomeFree cash flow
2025$3.9B$-724.0K$113.1M
2024$2.7B$-128.0M$-6.6M
2023$1.8B$-148.0M$-95.2M
2022$1.4B$-149.5M$-69.2M
2021$1.2B$-195.3M$-78.8M
2020$959.2M$-22.9M$7.6M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +40.2%.

Earnings

Next report: –
No EPS history available.

Stats refreshed – ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

COTEAU

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026